Bionano Genomics (BNGO) Free Cash Flow (2017 - 2026)
Bionano Genomics (BNGO) reported Free Cash Flow of -$5.7 million for Q1 2026, down 133.53% on a YoY basis from $17.0 million in Q1 2025, and down 37.63% sequentially from -$4.1 million in Q4 2025.
Bionano Genomics (BNGO) Free Cash Flow (2017 - 2026) Analysis & Trends
Bionano Genomics (BNGO) has 10 years of Free Cash Flow data on file, last reported at -$5.7 million in Q1 2026.
- For the quarter ending Q1 2026, Free Cash Flow fell 133.53% year-over-year to -$5.7 million; the trailing twelve-month figure through Mar 2026 stood at -$19.6 million (up 49.25% YoY), and the FY2025 full-year result was -$16.3 million, up 74.63% from the prior year.
- Free Cash Flow retreated to -$5.7 million in Q1 2026, from -$4.1 million in the prior quarter.
- In the past five years, Free Cash Flow ranged from a high of -$1.7 million in Q4 2024 to a low of -$36.4 million in Q2 2023.
- A 5-year average of -$20.0 million and a median of -$26.6 million in 2023 frame the typical range for Free Cash Flow.
- Across the five-year window, Free Cash Flow soared 94.45% in 2024 and sank 139.7% in 2025, its largest moves.
- Tracing BNGO's Free Cash Flow over 5 years: stood at -$36.1 million in 2022, then rose by 13.95% to -$31.0 million in 2023, then soared by 94.45% to -$1.7 million in 2024, then sank by 139.7% to -$4.1 million in 2025, then tumbled by 37.63% to -$5.7 million in 2026.
- Business Quant data shows BNGO's Free Cash Flow at -$5.7 million in Q1 2026, -$4.1 million in Q4 2025, and -$5.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | 557.00 Mn |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | 1.10 Bn |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | 546.00 Mn |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | 316.00 Mn |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | 520.48 Mn |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | 80.80 Mn |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | 96.40 Mn |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | -273.00 Mn |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | 120.26 Mn |
| 10 | Bionano Genomics | 4.34 Mn | -9.35 Mn | 3.25 Mn | -5.68 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -5.68 Mn |
| Mar 31, 2026 | -5.68 Mn |
| Dec 31, 2025 | -4.13 Mn |
| Dec 31, 2025 | -4.13 Mn |
| Sep 30, 2025 | -5.92 Mn |
| Sep 30, 2025 | -5.92 Mn |
| Jun 30, 2025 | -3.82 Mn |
| Jun 30, 2025 | -3.82 Mn |
| Mar 31, 2025 | -2.43 Mn |
| Mar 31, 2025 | -2.43 Mn |
| Dec 31, 2024 | -1.72 Mn |
| Dec 31, 2024 | -1.72 Mn |
| Sep 30, 2024 | -13.31 Mn |
| Sep 30, 2024 | -13.31 Mn |
| Jun 30, 2024 | -21.06 Mn |
| Jun 30, 2024 | -21.06 Mn |
| Mar 31, 2024 | -28.16 Mn |
| Mar 31, 2024 | -28.16 Mn |
| Dec 31, 2023 | -31.04 Mn |
| Dec 31, 2023 | -31.04 Mn |